OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 37 filers reported holding OVID THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548,576 | +17.1% | 142,858 | +0.0% | 0.00% | – |
| Q2 2023 | $468,509 | +27.1% | 142,838 | 0.0% | 0.00% | – |
| Q1 2023 | $368,522 | +549932.8% | 142,838 | +300.1% | 0.00% | – |
| Q4 2022 | $67 | -99.9% | 35,704 | -14.4% | 0.00% | – |
| Q3 2022 | $77,000 | +26.2% | 41,720 | +113.2% | 0.00% | – |
| Q1 2022 | $61,000 | -3.2% | 19,564 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -79.2% | 19,564 | -63.0% | 0.00% | – |
| Q3 2020 | $303,000 | -22.1% | 52,819 | 0.0% | 0.00% | – |
| Q2 2020 | $389,000 | +111.4% | 52,819 | -14.5% | 0.00% | – |
| Q1 2020 | $184,000 | -51.1% | 61,794 | -31.9% | 0.00% | – |
| Q4 2019 | $376,000 | +27.9% | 90,701 | 0.0% | 0.00% | – |
| Q3 2019 | $294,000 | +75.0% | 90,701 | 0.0% | 0.00% | – |
| Q2 2019 | $168,000 | +4.3% | 90,701 | 0.0% | 0.00% | – |
| Q1 2019 | $161,000 | -23.7% | 90,701 | +3.9% | 0.00% | – |
| Q4 2018 | $211,000 | -52.5% | 87,257 | +11.5% | 0.00% | – |
| Q3 2018 | $444,000 | – | 78,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
| Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
| CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
| Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
| BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
| EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
| Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
| Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
| DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |